Fabian Schuh

German Society of Surgery

Papers

1

Total Citations

11

H-Index

1

About

Fabian Schuh is a leading surgical researcher whose work centers on advancing pancreatic surgery through rigorous clinical trials. His primary research areas include minimally invasive surgical techniques, postoperative outcomes, and comparative effectiveness in pancreatic resections. Schuh’s most significant contribution is his role in the DISPACT-2 trial, a landmark randomised controlled trial comparing minimally invasive distal pancreatectomy (MIDP) to open surgery. This study addresses a critical gap in evidence, as MIDP has gained popularity for faster recovery, yet its safety and complication rates—historically 30–40% in distal pancreatectomy—require robust validation. With 11 citations since 2021, the protocol has already shaped surgical practice by establishing a framework for evaluating postoperative complications. Schuh’s work exemplifies how methodologically sound trials can guide clinical decision-making, balancing innovation with patient safety. His research is essential reading for surgeons and trainees navigating the shift toward minimally invasive approaches, offering data-driven insights into optimizing recovery without compromising outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Protocol for a randomised controlled trial to compare postoperative complications between minimally invasive and open DIStal PAnCreaTectomy (DISPACT-2 trial)
11 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: German Society of Surgery

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago